CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.


Begin main content


Last Updated: February 29, 2012
Result type: Reports
Project Number: SR0273-000
Product Line: Reimbursement Review

Generic Name: Indacaterol

Brand Name: Onbrez

Manufacturer: Novartis Pharmaceuticals Canada Inc.

Therapeutic Area: Chronic obstructive pulmonary disease

Indications: Chronic Obstructive Pulmonary Disease (COPD), maintenance bronchodilator treatment

Submission Type: Initial

Project Status: Complete

Date Recommendation Issued: August 16, 2012

Recommendation Type: List in a similar manner